financetom
Business
financetom
/
Business
/
Haemonetics Secures CE Mark for SavvyWire Guidewire
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Haemonetics Secures CE Mark for SavvyWire Guidewire
Jul 30, 2024 10:17 AM

12:53 PM EDT, 07/30/2024 (MT Newswires) -- Haemonetics ( HAE ) said Tuesday that it has obtained CE Mark certification for the SavvyWire Pre-Shaped Pressure Guidewire.

The certification allows Haemonetics ( HAE ) to proceed with the commercial introduction of the SavvyWire guidewire in the European Union and other regions recognizing the CE Mark, Haemonetics ( HAE ) said.

The SavvyWire is a sensor-guided 3-in-1 solution for Transcatheter Aortic Valve Implantation (TAVI), offering "wire performance, hemodynamic measurement and left-ventricular pacing capabilities," according to the company statement.

Haemonetics ( HAE ) shares was down 0.4% in recent trading.

Price: 89.40, Change: -0.34, Percent Change: -0.38

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rheinmetall wants to take over German shipbuilder NVL, Bild reports
Rheinmetall wants to take over German shipbuilder NVL, Bild reports
Aug 27, 2025
BERLIN, Aug 27 (Reuters) - Defence group Rheinmetall wants to take over German shipbuilder Naval Vessels Luerssen, the German daily Bild reported on Wednesday, citing industry sources. According to Bild, the Luerssen family, who own the shipbuilder, plan to divest its military shipyards in Hamburg, Wilhelmshaven and Wolgast to focus on building megayachts. Rheinmetall's supervisory board intends to consider the...
Abercrombie & Fitch Lifts Full-Year Guidance as Second-Quarter Results Top Views
Abercrombie & Fitch Lifts Full-Year Guidance as Second-Quarter Results Top Views
Aug 27, 2025
01:20 PM EDT, 08/27/2025 (MT Newswires) -- Abercrombie & Fitch ( ANF ) upgraded its fiscal 2025 outlook on Wednesday after the apparel retailer's second-quarter results exceeded Wall Street's estimates, though earnings fell year over year. The company now expects full-year earnings between $10 and $10.50 per share, lifting the middle point versus its prior outlook of $9.50 to $10.50....
What's Going On With Palantir Technologies Stock?
What's Going On With Palantir Technologies Stock?
Aug 27, 2025
Shares of Palantir Technologies Inc ( PLTR ) are trading lower Wednesday afternoon, continuing a recent pullback from all-time highs. Here’s what investors need to know. What To Know: The stock, a top performer this year with gains of over 100%, is now a battleground between bullish enthusiasm for its AI prowess and bearish warnings over its stretched valuation. Adding...
Vor Bio's Investigational Drug Scores Phase 3 Win In Autoimmune Kidney Disease Trial
Vor Bio's Investigational Drug Scores Phase 3 Win In Autoimmune Kidney Disease Trial
Aug 27, 2025
On Wednesday, Vor Bio Inc. announced that its collaborator, RemeGen Co., Ltd., achieved the primary endpoint in Stage A of a Phase 3 clinical study in China evaluating telitacicept in adults with IgA nephropathy (IgAN). IgA nephropathy, also known as Berger’s disease, is an autoimmune kidney disease where abnormal clumps of the antibody immunoglobulin A (IgA) deposit in the kidneys’...
Copyright 2023-2026 - www.financetom.com All Rights Reserved